"Unrealistic Optimism" Komen Blog

The New York Times recently featured a story raising concerns about the “unrealistic optimism” that many cancer patients have who sign up for early Phase I or II clinical trials. Some doctors and ethicists worried that too many volunteers have their hopes too high that the drug or treatment being tested will conquer their cancer. But George Sledge, M.D., a member of our Scientific Advisory Board, isn’t all that concerned about the volunteers’ high hopes. In fact, as he writes in the current edition of the ASCO Connection, he’s proud of them.

Check out Dr. Sledge’s article here.